State’s biggest drug supplier excluded from price talks
The existing agreement that the state has with the pharmaceutical sector is due to expire at the end of this month
The biggest supplier of medicines in the state will be excluded from talks on a new drug pricing agreement, Minister for Health Leo Varadkar has said.
The company, Teva, recently established the Healthcare Enterprise Alliance (HEA), which includes large generic manufacturers Mylan and Krka Pharmaceuticals.
The three companies, which employ approximately 2,000 people across the country, claimed the state could get savings of approximately €130 million on medicines that are supplied in hospitals, as well...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Analysis: Variants and vaccines make projecting path of virus more complex
While the vaccine rollout should reduce the number of new Covid-19 cases, the increased transmissibility of the new variant mean progress in suppressing the virus has slowed
HSE’s latest private hospitals Covid deal estimated to cost €47 million a month
HSE considers ending surge capacity arrangements with private hospitals as number of Covid-19 hospitalisations falls
Key public health posts remain vacant
Frustrated doctors snub HSE jobs as talks over the long-promised consultant contract stall
Breakdown of HSE’s €1.6 billion war chest to fight Covid-19
The National Service Plan shows that €200m of the €1.6bn allocated to fighting the pandemic is to be spent on the rollout of vaccinations
